- Home
- DV vs DNLI Comparison
DV vs DNLI Comparison
Compare DV & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DV
- DNLI
- Stock Information
- Founded
- DV 2008
- DNLI 2013
- Country
- DV United States
- DNLI United States
- Employees
- DV N/A
- DNLI N/A
- Industry
- DV Computer Software: Prepackaged Software
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DV Technology
- DNLI Health Care
- Exchange
- DV Nasdaq
- DNLI Nasdaq
- Market Cap
- DV 2.5B
- DNLI 2.1B
- IPO Year
- DV 2021
- DNLI 2017
- Fundamental
- Price
- DV $15.00
- DNLI $15.43
- Analyst Decision
- DV Buy
- DNLI Strong Buy
- Analyst Count
- DV 19
- DNLI 15
- Target Price
- DV $19.18
- DNLI $33.62
- AVG Volume (30 Days)
- DV 2.1M
- DNLI 2.0M
- Earning Date
- DV 08-05-2025
- DNLI 11-05-2025
- Dividend Yield
- DV N/A
- DNLI N/A
- EPS Growth
- DV N/A
- DNLI N/A
- EPS
- DV 0.31
- DNLI N/A
- Revenue
- DV $714,259,000.00
- DNLI N/A
- Revenue This Year
- DV $18.49
- DNLI N/A
- Revenue Next Year
- DV $11.80
- DNLI $802.87
- P/E Ratio
- DV $47.71
- DNLI N/A
- Revenue Growth
- DV 16.54
- DNLI N/A
- 52 Week Low
- DV $11.52
- DNLI $10.57
- 52 Week High
- DV $23.11
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- DV 40.12
- DNLI 56.61
- Support Level
- DV $15.54
- DNLI $14.52
- Resistance Level
- DV $16.28
- DNLI $16.20
- Average True Range (ATR)
- DV 0.50
- DNLI 0.70
- MACD
- DV -0.10
- DNLI -0.01
- Stochastic Oscillator
- DV 3.00
- DNLI 62.44
About DV DoubleVerify Holdings Inc.
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.